Oral solution of abacavir, a nucleoside reverse transcriptase inhibitor for pediatric and adult HIV treatment. Administered in community health center...

Nucleoside reverse transcriptase inhibitors offered as scored oral tablets for pediatric and adult HIV care. Supplied by contract manufacturers to int...

Class of pharmaceuticals targeting HIV replication through various mechanisms including reverse transcriptase and protease inhibition. Bulk manufactur...

Combination antiretroviral formulations for HIV management, supplied as oral tablets. Pharmaceutical manufacturers produce for distribution to hospita...

Protease inhibitor encapsulated for once-daily dosing in HIV antiretroviral regimens, often boosted with ritonavir. Fabricated by branded and generic ...

Nucleotide analogue antiviral injection for cytomegalovirus retinitis in AIDS patients. Prepared by compounding pharmacies and manufacturers, administ...

Co-formulated protease inhibitors in tablet dosage for multidrug-resistant HIV-1 treatment. Developed by pharmaceutical alliances, supplied to treatme...

Protease inhibitors in tablet dosage for boosted regimens in treatment-experienced HIV patients. Formulated and distributed by specialty pharmaceutica...

Nucleoside analog in capsule form for antiretroviral HIV treatment. Supplied by producers to wholesalers, pharmacies, and medical facilities for procu...

Fixed-dose combination tablets integrating integrase inhibitor, nucleoside reverse transcriptase inhibitors for simplified HIV therapy. Manufactured b...

Integrase strand transfer inhibitors available as single-entity oral tablets for HIV-1 suppression. Sourced from international pharmaceutical supplier...

Non-nucleoside reverse transcriptase inhibitor tablets for HIV treatment. Procured by international aid organizations and hospital networks from suppl...

Dual nucleoside analog reverse transcriptase inhibitor tablets for HIV regimens. Suppliers deliver to distributors, clinics, and hospital pharmacies f...

Non-nucleoside reverse transcriptase inhibitor tablets for HIV treatment. Manufacturers distribute to pharmaceutical wholesalers and healthcare provid...

Non-nucleoside reverse transcriptase inhibitor in capsule dosage for HIV therapy. Pharmaceutical producers supply to global wholesalers and treatment ...

Nucleoside reverse transcriptase inhibitor available in oral formulations for HIV protocols. Manufacturers offer to pharmaceutical distributors and he...

Fixed-dose combination of nucleoside and nucleotide reverse transcriptase inhibitors in tablet form for HIV-1 treatment and pre-exposure prophylaxis. ...

Oral non-nucleoside reverse transcriptase inhibitor for resistant HIV strains. Sourced by procurement professionals in infectious disease units from g...

Fixed-dose combination tablets integrating multiple antiretrovirals for HIV control. Produced by pharmaceutical firms for supply chains serving hospit...

Protease inhibitor in capsule form for HIV therapy regimens. Suppliers provide to wholesalers, hospitals, and outpatient pharmacies for use by virolog...

Etravirine tablets functioning as non-nucleoside reverse transcriptase inhibitors for multidrug-resistant HIV. Prescribed in specialized care units an...

Combination nucleoside reverse transcriptase inhibitor tablets for HIV therapy. Purchased by procurement departments in healthcare systems from drug m...

Fixed-dose combination tablets with lamivudine, stavudine, and nevirapine for antiretroviral therapy in HIV treatment. Utilized by hospitals, clinics,...

Nucleoside reverse transcriptase inhibitors in tablet form for HIV and hepatitis B co-infection management. Generic producers export to B2B buyers inc...

Fixed-dose combination protease inhibitor tablets for HIV antiretroviral regimens. Acquired by global health programs, pharmacies, and medical facilit...

CCR5 receptor antagonist in tablet form for treatment-experienced patients with CCR5-tropic HIV-1. Manufactured by specialty pharmaceutical companies,...

Mesylate salt form of oral protease inhibitor for managing HIV infection. Supplied to distributors and healthcare providers by pharmaceutical companie...

Oral protease inhibitor formulation for HIV treatment protocols. Sourced by healthcare procurement teams from generic and branded suppliers for use in...

Non-nucleoside reverse transcriptase inhibitor available as tablets for initial HIV therapy and prevention of mother-to-child transmission. Produced b...

Integrase strand transfer inhibitor in oral tablet formulation for antiretroviral therapy in HIV-1 management. Supplied by pharmaceutical manufacturer...

Rilpivirine tablets as non-nucleoside reverse transcriptase inhibitors in fixed-dose regimens for HIV. Deployed in primary care and outpatient service...

Protease inhibitor tablets primarily used as pharmacokinetic boosters in HIV regimens. Distributed to pharmacies and clinics by pharmaceutical interme...

Nucleoside reverse transcriptase inhibitor capsules used in HIV regimens. Employed in outpatient clinics and treatment centers. Produced by active pha...

Tablets combining darunavir and ritonavir as protease inhibitors for HIV management. Applied in clinical settings by physicians and pharmacists. Sourc...

Prodrug formulations of tenofovir as oral tablets, serving as nucleotide reverse transcriptase inhibitors in HIV treatment protocols. Produced by gene...

Nucleotide reverse transcriptase inhibitors formulated as oral tablets for antiretroviral therapy in HIV management. Pharmaceutical manufacturers supp...

Fixed-dose combination of nucleoside reverse transcriptase inhibitor, nucleoside analogue, and non-nucleoside inhibitor in tablets for first-line HIV ...

Combination tablets with abacavir, lamivudine, and zidovudine for initial HIV therapy lines. Used by general practitioners and HIV clinics. Procured f...

Didanosine capsules serving as nucleoside analogs in HIV therapy. Integrated into treatment plans by infectious disease specialists in hospitals. Acqu...

Oral nucleoside reverse transcriptase inhibitor used in antiretroviral therapy for HIV management. Procured by hospitals, clinics, and public health o...